Annual CFO:
-$142.11M-$65.35M(-85.13%)Summary
- As of today, SMMT annual cash from operations is -$142.11 million, with the most recent change of -$65.35 million (-85.13%) on December 31, 2024.
- During the last 3 years, SMMT annual cash from operations has fallen by -$69.52 million (-95.77%).
- SMMT annual cash from operations is now -977.53% below its all-time high of $16.19 million, reached on January 31, 2017.
Performance
SMMT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$95.02M-$24.43M(-34.60%)Summary
- As of today, SMMT quarterly cash from operations is -$95.02 million, with the most recent change of -$24.43 million (-34.60%) on September 30, 2025.
- Over the past year, SMMT quarterly cash from operations has dropped by -$62.77 million (-194.68%).
- SMMT quarterly cash from operations is now -362.09% below its all-time high of $36.25 million, reached on October 31, 2016.
Performance
SMMT Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$274.08M-$62.77M(-29.71%)Summary
- As of today, SMMT TTM cash from operations is -$274.08 million, with the most recent change of -$62.77 million (-29.71%) on September 30, 2025.
- Over the past year, SMMT TTM cash from operations has dropped by -$160.66 million (-141.66%).
- SMMT TTM cash from operations is now -1005.03% below its all-time high of $30.28 million, reached on July 31, 2017.
Performance
SMMT TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SMMT Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -85.1% | -194.7% | -141.7% |
| 3Y3 Years | -95.8% | -1330.4% | -432.5% |
| 5Y5 Years | -611.2% | -441.7% | -573.5% |
SMMT Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -241.8% | at low | -2457.5% | at low | -712.7% | at low |
| 5Y | 5-Year | -611.2% | at low | -2457.5% | at low | -712.7% | at low |
| All-Time | All-Time | -977.5% | at low | -362.1% | at low | -1005.0% | at low |
SMMT Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$95.02M(-34.6%) | -$274.08M(-29.7%) |
| Jun 2025 | - | -$70.59M(-15.4%) | -$211.30M(-21.7%) |
| Mar 2025 | - | -$61.17M(-29.3%) | -$173.56M(-21.8%) |
| Dec 2024 | -$142.11M(-85.1%) | -$47.30M(-46.7%) | -$142.53M(-25.7%) |
| Sep 2024 | - | -$32.24M(+1.8%) | -$113.42M(-17.5%) |
| Jun 2024 | - | -$32.85M(-9.0%) | -$96.55M(-3.1%) |
| Mar 2024 | - | -$30.13M(-65.7%) | -$93.61M(-22.2%) |
| Dec 2023 | -$76.76M(-84.6%) | -$18.19M(-18.3%) | -$76.61M(-40.9%) |
| Sep 2023 | - | -$15.37M(+48.6%) | -$54.39M(-19.1%) |
| Jun 2023 | - | -$29.92M(-127.8%) | -$45.66M(-35.4%) |
| Mar 2023 | - | -$13.13M(-425.8%) | -$33.73M(+14.8%) |
| Dec 2022 | -$41.58M(+42.7%) | $4.03M(+160.7%) | -$39.60M(+23.1%) |
| Sep 2022 | - | -$6.64M(+63.1%) | -$51.47M(+24.3%) |
| Jun 2022 | - | -$17.98M(+5.4%) | -$67.99M(+2.1%) |
| Mar 2022 | - | -$19.00M(-142.1%) | -$69.46M(+2.3%) |
| Dec 2021 | -$72.59M(-50.9%) | -$7.85M(+66.1%) | -$71.13M(+1.4%) |
| Sep 2021 | - | -$23.16M(-19.0%) | -$72.13M(-8.4%) |
| Jun 2021 | - | -$19.46M(+5.9%) | -$66.51M(-7.9%) |
| Mar 2021 | - | -$20.67M(-133.7%) | -$61.65M(-24.4%) |
| Dec 2020 | -$48.11M(-140.8%) | - | - |
| Dec 2020 | - | -$8.84M(+49.6%) | -$49.54M(-21.7%) |
| Sep 2020 | - | -$17.54M(-20.2%) | -$40.70M(-75.7%) |
| Jun 2020 | - | -$14.60M(-70.5%) | -$23.16M(-170.5%) |
| Mar 2020 | - | -$8.56M(-52.1%) | -$8.56M(+75.1%) |
| Dec 2019 | -$19.98M(-4.7%) | - | - |
| Jan 2019 | - | -$5.63M(-12.8%) | -$34.36M(+6.7%) |
| Oct 2018 | - | -$4.99M(+64.3%) | -$36.82M(+19.1%) |
| Jul 2018 | - | -$14.00M(-43.7%) | -$45.52M(-132.3%) |
| Apr 2018 | - | -$9.74M(-20.4%) | -$19.60M(+0.9%) |
| Jan 2018 | -$19.08M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2018 | - | -$8.09M(+40.9%) | -$19.78M(-0.6%) |
| Oct 2017 | - | -$13.69M(-214.8%) | -$19.67M(-164.9%) |
| Jul 2017 | - | $11.93M(+220.2%) | $30.28M(+112.5%) |
| Apr 2017 | - | -$9.93M(-24.5%) | $14.25M(-5.5%) |
| Jan 2017 | $16.19M(+162.1%) | - | - |
| Jan 2017 | - | -$7.97M(-122.0%) | $15.09M(+2.1%) |
| Oct 2016 | - | $36.25M(+983.3%) | $14.77M(+153.0%) |
| Jul 2016 | - | -$4.10M(+54.9%) | -$27.89M(+3.0%) |
| Apr 2016 | - | -$9.09M(-9.7%) | -$28.75M(-12.9%) |
| Jan 2016 | -$26.10M(-41.6%) | - | - |
| Jan 2016 | - | -$8.28M(-29.3%) | -$25.47M(-17.6%) |
| Oct 2015 | - | -$6.41M(-29.0%) | -$21.65M(-17.6%) |
| Jul 2015 | - | -$4.96M(+14.6%) | -$18.41M(+7.9%) |
| Apr 2015 | - | -$5.81M(-30.3%) | -$19.99M(-20.5%) |
| Jan 2015 | -$18.43M(-100.7%) | - | - |
| Jan 2015 | - | -$4.46M(-41.1%) | -$16.59M(-36.8%) |
| Oct 2014 | - | -$3.16M(+51.6%) | -$12.12M(-35.3%) |
| Jul 2014 | - | -$6.54M(-170.8%) | -$8.96M(-270.8%) |
| Apr 2014 | - | -$2.42M | -$2.42M |
| Jan 2014 | -$9.18M(-82.1%) | - | - |
| Jan 2013 | -$5.04M(-30.6%) | - | - |
| Jan 2012 | -$3.86M(+8.1%) | - | - |
| Jan 2011 | -$4.20M(+15.5%) | - | - |
| Jan 2010 | -$4.97M(+71.9%) | - | - |
| Jan 2009 | -$17.68M(-20.4%) | - | - |
| Jan 2008 | -$14.69M(-251.9%) | - | - |
| Jan 2007 | -$4.17M(-153.4%) | - | - |
| Jan 2006 | -$1.65M(-3041.6%) | - | - |
| Jan 2005 | $56.00K(+147.3%) | - | - |
| Jan 2004 | -$118.40K | - | - |
FAQ
- What is Summit Therapeutics Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Summit Therapeutics Inc.?
- What is Summit Therapeutics Inc. annual cash from operations year-on-year change?
- What is Summit Therapeutics Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Summit Therapeutics Inc.?
- What is Summit Therapeutics Inc. quarterly cash from operations year-on-year change?
- What is Summit Therapeutics Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Summit Therapeutics Inc.?
- What is Summit Therapeutics Inc. TTM cash from operations year-on-year change?
What is Summit Therapeutics Inc. annual cash from operations?
The current annual cash from operations of SMMT is -$142.11M
What is the all-time high annual cash from operations for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high annual cash from operations is $16.19M
What is Summit Therapeutics Inc. annual cash from operations year-on-year change?
Over the past year, SMMT annual cash from operations has changed by -$65.35M (-85.13%)
What is Summit Therapeutics Inc. quarterly cash from operations?
The current quarterly cash from operations of SMMT is -$95.02M
What is the all-time high quarterly cash from operations for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high quarterly cash from operations is $36.25M
What is Summit Therapeutics Inc. quarterly cash from operations year-on-year change?
Over the past year, SMMT quarterly cash from operations has changed by -$62.77M (-194.68%)
What is Summit Therapeutics Inc. TTM cash from operations?
The current TTM cash from operations of SMMT is -$274.08M
What is the all-time high TTM cash from operations for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high TTM cash from operations is $30.28M
What is Summit Therapeutics Inc. TTM cash from operations year-on-year change?
Over the past year, SMMT TTM cash from operations has changed by -$160.66M (-141.66%)